C34
Conditions
Interventions
Group 1: Patients receiving guideline-oriented therapy of lung carcinoma according to the advice of the tumor board (DKG standard). The add-on Viscum album therapy ist offered to the patients and is n
Sponsors
Forschungsinstitut Havelhöhe (FIH) gGmbH am Gemeinschaftskrankenhaus Havelhöhe
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: Written informed consent, patients with primary lung carcinoma (stage UICC IIA - IVB - 8th edition), knowledge of Geman language, can expected to undergo a 3-months program (ECOG 0-2), inclusion within 4 weeks of primary diagnosis, if necessary plus 3 months depending on therapy
Exclusion criteria
Exclusion criteria: Primary lung carcinoma UICC I (8th edition), no written consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| QoL (Quality of life): FACT-TOI questionnaire, at the time points 0, 3, 6 und 12 , 24 und 36 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety, adverse events, Tumor Response Rate, QoL (Quality of Life) with the questionnaires FACT-L, FACT-TOI, CFS-D, PSQI, HADS, IPQR, F-Sozu, FEAV, PAF, State aR, Grossarth-Maticek's self-regulation and distress barometer, in addition overall survival and progression free survival; time points 0, 3, 6 und 12 , 24 und 36 weeks | — |
Countries
Germany
Contacts
Public ContactChristian Grah
Forschungsinstitut Havelhöhe (FIH) gGmbH am Gemeinschaftskrankenhaus Havelhöhe
Outcome results
None listed